Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines - PubMed (original) (raw)
Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines
Michael E Ray et al. Cancer Res. 2004.
Abstract
Gene amplification is an important mechanism of oncogene activation in breast and other cancers. Characterization of amplified regions of the genome in breast cancer has led to the identification of important oncogenes including erbB-2/HER-2, C-MYC, and fibroblast growth factor receptor (FGFR) 2. Chromosome 8p11-p12 is amplified in 10-15% of human breast cancers. The putative oncogene FGFR1 localizes to this region; however, we show evidence that FGFR inhibition fails to slow growth of three breast cancer cell lines with 8p11-p12 amplification. We present a detailed analysis of this amplicon in three human breast cancer cell lines using comparative genomic hybridization, traditional Southern and Northern analysis, and chromosome 8 cDNA microarray expression profiling. This study has identified new candidate oncogenes within the 8p11-p12 region, supporting the hypothesis that genes other than FGFR1 may contribute to oncogenesis in breast cancers with proximal 8p amplification.
Similar articles
- A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes.
Garcia MJ, Pole JC, Chin SF, Teschendorff A, Naderi A, Ozdag H, Vias M, Kranjac T, Subkhankulova T, Paish C, Ellis I, Brenton JD, Edwards PA, Caldas C. Garcia MJ, et al. Oncogene. 2005 Aug 4;24(33):5235-45. doi: 10.1038/sj.onc.1208741. Oncogene. 2005. PMID: 15897872 - Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines.
Yang ZQ, Albertson D, Ethier SP. Yang ZQ, et al. Cancer Genet Cytogenet. 2004 Nov;155(1):57-62. doi: 10.1016/j.cancergencyto.2004.03.013. Cancer Genet Cytogenet. 2004. PMID: 15527903 - Comprehensive profiling of 8p11-12 amplification in breast cancer.
Gelsi-Boyer V, Orsetti B, Cervera N, Finetti P, Sircoulomb F, Rougé C, Lasorsa L, Letessier A, Ginestier C, Monville F, Esteyriès S, Adélaïde J, Esterni B, Henry C, Ethier SP, Bibeau F, Mozziconacci MJ, Charafe-Jauffret E, Jacquemier J, Bertucci F, Birnbaum D, Theillet C, Chaffanet M. Gelsi-Boyer V, et al. Mol Cancer Res. 2005 Dec;3(12):655-67. doi: 10.1158/1541-7786.MCR-05-0128. Mol Cancer Res. 2005. PMID: 16380503 - Amplification of 8p11.23 in cancers and the role of amplicon genes.
Voutsadakis IA. Voutsadakis IA. Life Sci. 2021 Jan 1;264:118729. doi: 10.1016/j.lfs.2020.118729. Epub 2020 Nov 6. Life Sci. 2021. PMID: 33166592 Review. - The 17q23 amplicon and breast cancer.
Sinclair CS, Rowley M, Naderi A, Couch FJ. Sinclair CS, et al. Breast Cancer Res Treat. 2003 Apr;78(3):313-22. doi: 10.1023/a:1023081624133. Breast Cancer Res Treat. 2003. PMID: 12755490 Review.
Cited by
- Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance.
Krook MA, Reeser JW, Ernst G, Barker H, Wilberding M, Li G, Chen HZ, Roychowdhury S. Krook MA, et al. Br J Cancer. 2021 Mar;124(5):880-892. doi: 10.1038/s41416-020-01157-0. Epub 2020 Dec 3. Br J Cancer. 2021. PMID: 33268819 Free PMC article. Review. - A meta-analysis of BRF2 as a prognostic biomarker in invasive breast carcinoma.
Cabarcas-Petroski S, Meneses PI, Schramm L. Cabarcas-Petroski S, et al. BMC Cancer. 2020 Nov 11;20(1):1093. doi: 10.1186/s12885-020-07569-8. BMC Cancer. 2020. PMID: 33176745 Free PMC article. - FGF2-Derived PeptibodyF2-MMAE Conjugate for Targeted Delivery of Cytotoxic Drugs into Cancer Cells Overexpressing FGFR1.
Jendryczko K, Chudzian J, Skinder N, Opaliński Ł, Rzeszótko J, Wiedlocha A, Otlewski J, Szlachcic A. Jendryczko K, et al. Cancers (Basel). 2020 Oct 15;12(10):2992. doi: 10.3390/cancers12102992. Cancers (Basel). 2020. PMID: 33076489 Free PMC article. - The UPR Transducer IRE1 Promotes Breast Cancer Malignancy by Degrading Tumor Suppressor microRNAs.
Zhang K, Liu H, Song Z, Jiang Y, Kim H, Samavati L, Nguyen HM, Yang ZQ. Zhang K, et al. iScience. 2020 Aug 25;23(9):101503. doi: 10.1016/j.isci.2020.101503. eCollection 2020 Sep 25. iScience. 2020. PMID: 32911332 Free PMC article. - Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients.
Erber R, Rübner M, Davenport S, Hauke S, Beckmann MW, Hartmann A, Häberle L, Gass P, Press MF, Fasching PA. Erber R, et al. Breast Cancer Res Treat. 2020 Nov;184(2):311-324. doi: 10.1007/s10549-020-05865-2. Epub 2020 Aug 27. Breast Cancer Res Treat. 2020. PMID: 32852708 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous